Resources
Resources provided by Halteres Associates highlight the thought leadership and deep group expertise our team offers its clients and constituents.
Tools for COVID-19 Diagnostics Development and Application
- Overview of COVID-19 Diagnostic Tools
- Value Creation Roadmap for Diagnostic Developers
- COVID-19 Use Case Definitions
- COVID-19 Use Settings (Storyboards)
Diagnostics Reports
- November 2020 Report on Landscape of Companies for Influenza Tests
- March 2020 COVID-19 Diagnostic Use Cases (Use Case Tables)
- January 2018 Diagnostics Report Issue 2
- Diagnostics: a key component of health system strengthening November 2017
Presentations
- Roadmap to Value Creation in Molecular Diagnostics
- Case Study: Strategic Options - Clinical Diagnostics for Iconix Biosciences, Inc.
- High Impact Diagnostics
- POC Testing - The Time is Now
Publications
- Post-Mortems on Diagnostic Testing Start-ups: Reports of Commercial Successes and Failures and the Case of the Zombie Life Science Company, BMJ Innovations, 2020
- Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South Africa, PLOS ONE, 2020.
- Requirements for High Impact Diagnostics in the Developing World Nature, 2006
Response
- Primum Non Nocere: Is the Performance of Available SARS-CoV-2 RNA and Immunoassays Good Enough To Do No Harm? AACC Artery Blog, April 14, 2020
White Papers
- An Assessment of the Technological Issues and Options for Point-Of-Care Diagnostic Tests in Resource-Limited Settings
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Status of Technologies and Approaches for Biomarker Discovery
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Bacterial and Severe Acute Lower Respiratory Tract Infection
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Giardia lamblia, Cryptosporidium parvum, and Enteroaggregative Escherichia coli in Children with Diarrhea as a Surrogate of Stunting
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of HIV Infection in Infants Less than Eighteen Months of Age
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Rapid, Home-based Diagnosis of Malaria in Symptomatic Individuals and Screening of Asymptomatic Pregnant Women
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Chlamydia trachomatis and Neisseria gonorrhea Infection in High-risk Women
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Syphilis in Asymptomatic Pregnant Women
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Tuberculosis in HIV Positive and HIV Negative Individuals
